Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Alopecia areata · Multiple myeloma

First Biotech (Australia)

Pfizer Australia Pty Ltd

First Biotech (Australia) clinical programs — 126 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
Status
Public
HQ
Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU
Founded
2017
Employees
2
Programs
126
Drugs
208
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Programs

First Biotech (Australia) projects

126 ClinicalTrials.gov programs sponsored by First Biotech (Australia).

First Biotech (Australia) has 126 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

126 programs

Clinical programs

Page 1 of 3

  1. A3921145

    Pfizer Australia Pty Ltd

    Juvenile Idiopathic Arthritis (JIA)

    phase 3 small molecule active

    1 trial

  2. A3921210

    Pfizer Australia Pty Ltd

    Ulcerative Colitis (UC)

    phase 3 small molecule active

    1 trial

  3. Abrocitinib

    Pfizer Australia Pty Ltd

    Moderate-to-Severe Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  4. Abrocitinib Placebo, Abrocitinib

    Pfizer Australia Pty Ltd

    Moderate-to-Severe Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  5. B7451015

    Pfizer Australia Pty Ltd

    Moderate to severe atopic dermatitis

    phase 3 small molecule active

    1 trial

  6. B7981027

    Pfizer Australia Pty Ltd

    Alopecia areata

    phase 3 small molecule active

    1 trial

  7. B7981028

    Pfizer Australia Pty Ltd

    Alopecia areata

    phase 3 small molecule active

    1 trial

  8. B7981041

    Pfizer Australia Pty Ltd

    NON SEGMENTAL VITILIGO

    phase 3 small molecule active

    1 trial

  9. B7981080

    Pfizer Australia Pty Ltd

    nonsegmental vitiligo

    phase 3 small molecule active

    1 trial

  10. B7981094

    Pfizer Australia Pty Ltd

    Alopecia areata

    phase 3 small molecule active

    1 trial

  11. B9991046

    Pfizer Australia Pty Ltd

    Cancer

    phase 3 small molecule active

    1 trial

  12. C0251010

    Pfizer Australia Pty Ltd

    Idiopathic Inflammatory Myopathy (including dermatomyositis or polymyositis)

    phase 3 small molecule active

    1 trial

  13. C0371017

    Pfizer Australia Pty Ltd

    hemophilia A, severe to moderately severe hemophilia B (FIX:C ≤ 2%)

    phase 3 small molecule active

    1 trial

  14. C1071005

    Pfizer Australia Pty Ltd

    MULTIPLE MYELOMA

    phase 3 small molecule active

    1 trial

  15. C1071006

    Pfizer Australia Pty Ltd

    Multiple myeloma

    phase 3 small molecule active

    1 trial

  16. C1071007

    Pfizer Australia Pty Ltd

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  17. C1071032

    Pfizer Australia Pty Ltd

    Relapsed/Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  18. C1091009

    Pfizer Australia Pty Ltd

    Group B streptococcus (GBS) disease

    phase 3 small molecule active

    1 trial

  19. C2321003

    Pfizer Australia Pty Ltd

    METASTATIC CASTRATION RESISTANT PROSTATE CANCER

    phase 3 small molecule active

    1 trial

  20. C2321008

    Pfizer Australia Pty Ltd

    METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER

    phase 3 small molecule active

    1 trial

  21. C2321014

    Pfizer Australia Pty Ltd

    METASTATIC CASTRATION RESISTANT PROSTATE CANCER

    phase 3 small molecule active

    1 trial

  22. C3391003

    Pfizer Australia Pty Ltd

    DUCHENNE MUSCULAR DYSTROPHY (DMD)

    phase 3 small molecule active

    1 trial

  23. C3441021

    Pfizer Australia Pty Ltd

    Metastatic Castration-resistant Prostate Cancer

    phase 3 small molecule active

    1 trial

  24. C3441052

    Pfizer Australia Pty Ltd

    Metastatic Castration-sensitive Prostate Cancer

    phase 3 small molecule active

    1 trial

  25. C3651021

    Pfizer Australia Pty Ltd

    Cancer cachexia

    phase 3 small molecule active

    1 trial

  26. C4221015

    Pfizer Australia Pty Ltd

    Colorectal cancer (BRAF V600E-mutant mCRC)

    phase 3 small molecule active

    1 trial

  27. C4221016

    Pfizer Australia Pty Ltd

    Metastatic or unresectable locally advanced BRAF V600E/K mutation positive melanoma

    phase 3 small molecule active

    1 trial

  28. C4391022

    Pfizer Australia Pty Ltd

    Hormone receptor-positive, her2-negative advanced/metastatic breast cancer

    phase 3 small molecule active

    1 trial

  29. C4391024

    Pfizer Australia Pty Ltd

    Advanced/Metastatic Breast Cancer

    phase 3 small molecule active

    1 trial

  30. C4551002

    Pfizer Australia Pty Ltd

    Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

    phase 3 small molecule active

    1 trial

  31. C4671026

    Pfizer Australia Pty Ltd

    SARS-CoV-2 Infection

    phase 3 small molecule active

    1 trial

  32. C4951002

    Pfizer Australia Pty Ltd

    Acute Migraine (with or without aura)

    phase 3 small molecule active

    1 trial

  33. C4951003

    Pfizer Australia Pty Ltd

    Acute Migraine (with or without aura)

    phase 3 small molecule active

    1 trial

  34. C4951009

    Pfizer Australia Pty Ltd

    Migraine (with or without aura)

    phase 3 small molecule active

    1 trial

  35. C4951013

    Pfizer Australia Pty Ltd

    Chronic Migraine

    phase 3 small molecule active

    1 trial

  36. C4951063

    Pfizer Australia Pty Ltd

    Menstrual Migraine

    phase 3 small molecule active

    1 trial

  37. C5091017

    Pfizer Australia Pty Ltd

    Covid-19 at high risk of progression to severe illness.

    phase 3 small molecule active

    1 trial

  38. C5091018

    Pfizer Australia Pty Ltd

    Coronavirus Disease 2019 (COVID-19)

    phase 3 small molecule active

    1 trial

  39. C5751003

    Pfizer Australia Pty Ltd

    non-small cell lung cancer

    phase 3 small molecule active

    1 trial

  40. C6461001

    Pfizer Australia Pty Ltd

    LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER

    phase 3 small molecule active

    1 trial

  41. C6461003

    Pfizer Australia Pty Ltd

    Metastatic Colorectal Cancer

    phase 3 small molecule active

    1 trial

  42. C6461004

    Pfizer Australia Pty Ltd

    Extensive-Stage Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  43. DOCETAXEL

    Pfizer Australia Pty Ltd

    Non-Small Cell Lung Cancer (NSCLC)

    phase 3 small molecule active

    1 trial

  44. ELRANATAMAB

    Pfizer Australia Pty Ltd

    Multiple myeloma

    phase 3 small molecule active

    1 trial

  45. LORLATINIB

    Pfizer Australia Pty Ltd

    Advanced ALK positive non-small cell lung cancer

    phase 3 small molecule active

    1 trial

  46. Ritlecitinib tosilate, Ritlecitinib Tosilate

    Pfizer Australia Pty Ltd

    Alopecia areata

    phase 3 small molecule active

    1 trial

  47. Sasanlimab

    Pfizer Australia Pty Ltd

    Non-Muscle Invasive Bladder Cancer

    phase 3 small molecule active

    1 trial

  48. giroctocogene fitelparvovec

    Pfizer Australia Pty Ltd

    hemophilia A

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does First Biotech (Australia) have?

126 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.